Related by context. Frequent words. (Click for all words.) 63 Phase Ib 59 PF # [001] 59 Phase 1b clinical 58 CYT# 57 phase IIb 56 Phase IIb clinical 56 tolerated dose MTD 55 Phase 2b study 55 Phase 1b 55 dose escalation trial 55 HGS ETR1 55 antitumor activity 55 Phase 2a trial 54 CoFactor 54 efficacy 54 immunogenicity 54 IMGN# 54 clinical endpoints 54 Phase IIa 54 Phase IIa trial 53 Phase 2b trial 53 Phase IIb 53 dosing regimens 53 dose escalation 53 ZYBRESTAT 53 Phase IIa clinical 53 Phase III clinical 53 pharmacokinetic profile 53 tolerability 53 efficacy endpoints 53 pharmacodynamics 52 pharmacodynamic 52 CA4P 52 phase 2a 52 Phase 2a 52 INCB# [002] 52 Serdaxin 52 picoplatin 52 Phase 2a clinical 52 randomized controlled clinical 51 randomized clinical 51 antithrombotic 51 NGX# 51 investigational 51 talactoferrin 51 biologic therapy 50 clinical trial 50 Phase 2b clinical 50 ISIS # 50 HspE7 49 FTY# 49 monotherapy 49 pharmacokinetics 49 adjuvant therapy 49 MGCD# [002] 49 FDG PET 49 elagolix 49 adalimumab 49 chemotherapeutic agents 49 pharmacokinetic 48 investigational compound 48 antiviral activity 48 vivo efficacy 48 Alpharadin 48 preclinical studies 48 investigational drug 48 orally administered 48 telbivudine 48 safety tolerability 48 azacitidine 48 prospective randomized 48 placebo controlled trials 48 randomized placebo controlled 48 cethromycin 48 bavituximab 48 lubiprostone 47 tolerability profile 47 lacosamide 47 Preclinical studies 47 bioequivalence 47 CRx 47 randomized controlled 47 adjunctive 47 clinical trials 47 bosentan 46 sustained virologic response 46 eltrombopag 46 antiplatelet 46 JANUVIA 46 randomized clinical trials 46 Phase III trials 46 preclinical 46 placebo controlled 46 GRN#L 46 vinorelbine 45 Adlea 45 randomized trials 45 Empatic 45 Phase III clinical trials 45 pharmacokinetic properties 45 bioactivity